We read with much interest the published article entitled “A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients with Ulcerative Colitis-Associated Colorectal Cancer” by Toiyama et al.1 At this juncture, we wish to express our scientific views on the published article.